GBIO - Generation Bio Co.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 296.91M
Enterprise Value 99.52M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.05
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.73

Trading Information

Stock Price History

Beta (5Y Monthly) 1.97
52-Week Change 3-25.62%
S&P500 52-Week Change 31.77%
52 Week High 38.7150
52 Week Low 33.4000
50-Day Moving Average 34.4632
200-Day Moving Average 35.0322

Share Statistics

Avg Vol (3 month) 3449.56k
Avg Vol (10 day) 3134.26k
Shares Outstanding 565.67M
Implied Shares Outstanding 6N/A
Float 848.48M
% Held by Insiders 114.71%
% Held by Institutions 196.51%
Shares Short (May 14, 2023) 42.11M
Short Ratio (May 14, 2023) 415.39
Short % of Float (May 14, 2023) 45.52%
Short % of Shares Outstanding (May 14, 2023) 43.21%
Shares Short (prior month Apr 13, 2023) 42.05M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-19.36%
Return on Equity (ttm)-42.32%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -130.34M
Net Income Avi to Common (ttm)-133.73M
Diluted EPS (ttm)-2.2200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)288.65M
Total Cash Per Share (mrq)4.39
Total Debt (mrq)82.36M
Total Debt/Equity (mrq)29.50
Current Ratio (mrq)15.16
Book Value Per Share (mrq)4.26

Cash Flow Statement

Operating Cash Flow (ttm)-94.69M
Levered Free Cash Flow (ttm)-108.75M